China: Northern Light leads $25m series B in clinical stage firm TenNor

Northern Light Venture Capital has led a $25-million series B financing in a clinical stage company TenNor Therapeutics, according to the company’s statement.

Existing investors Frontline BioVentures, WuXi Pharma Tech Healthcare Fund I, Oriza Venture Capital and Relativity Healthcare Fund also joined this round.

The company said that the proceeds will be used to advance new antibiotics into the late-stage of clinical development.

TenNor possesses a dual-acting drug discovery platform with several innovative products in various stages of preclinical and clinical development, while it keeps developing new drugs for other diseases continuously.

“With the infusion of the new capital, TenNor is well positioned to deliver the best treatment for H. pylori and other GI tract infections to patients in the coming years,” said TenNor’s founder and chief executive Dr. Zhenkun Ma.

TenNor Therapeutics was established in 2013 in BioBAY, a life science park based in Suzhou, China. It has acquired patents and other assets from Cumbre IP Venture and patents from the TB Alliance.

Northern Light Venture Capital is a China-focused venture capital firm targeting early stage opportunities of innovation and disruptive technology. Since its inception in 2005, Northern Light has backed over 180 ventures in TMT, healthcare and advanced technology.

Also read:

China: Shenma Jinrong raises $15m from Shunwei, Northern Light Venture

China: Northern Light Venture, New Horizon lead $100m Series D in Beibei.com

China’s WuXi PharmaTech tapping banks for $1.5b IPO for biologics arm

Singapore Reporter/s

In Singapore, we are looking to double our reporting team by this year-end to comprehensively cover the fast-moving world of funded startups and VC, PE & M&A deals. We want reporters who can tell our readers what is really happening in these sectors and why it matters to markets, companies and consumers. The ability to write precisely and urgently is crucial for these roles. Ideal candidates must have to ability to work in a collaborative, dynamic, and fast-changing environment. We want our new hires to be digitally savvy and ready to experiment with new forms of storytelling. Most importantly, we are looking for hard-hitting reporters who work well in a team. Collaboration and collegiality are a must.

Following vacancies can be applied for (only in Singapore).

Following vacancies can be applied for (only in Singapore).   

  • A reporter to track companies/startups that have raised private capital, and have the potential to become unicorns. SEA currently has over 40 companies with a valuation of over $100 million and under $1 billion.
  • A reporter who can get behind the scenes and reveal how funding rounds are put together, or why they’ve failed to materialise. She/he in this role will largely focus on long-format stories. 
  • A journalist to track special situations funds, distressed debt and private credit (from the PE angle) across Asia.

Singapore Reporter/s

In Singapore, we are looking to double our reporting team by this year-end to comprehensively cover the fast-moving world of funded startups and VC, PE & M&A deals. We want reporters who can tell our readers what is really happening in these sectors and why it matters to markets, companies and consumers. The ability to write precisely and urgently is crucial for these roles. Ideal candidates must have to ability to work in a collaborative, dynamic, and fast-changing environment. We want our new hires to be digitally savvy and ready to experiment with new forms of storytelling. Most importantly, we are looking for hard-hitting reporters who work well in a team. Collaboration and collegiality are a must.

Following vacancies can be applied for (only in Singapore).

Following vacancies can be applied for (only in Singapore).   

  • A reporter to track companies/startups that have raised private capital, and have the potential to become unicorns. SEA currently has over 40 companies with a valuation of over $100 million and under $1 billion.
  • A reporter who can get behind the scenes and reveal how funding rounds are put together, or why they’ve failed to materialise. She/he in this role will largely focus on long-format stories. 
  • A journalist to track special situations funds, distressed debt and private credit (from the PE angle) across Asia.